EMA Authorised: Actrapid (human insulin) — Novo Nordisk A/S

View source ↗

Summary

Actrapid (human insulin) by Novo Nordisk A/S has been authorised by the EMA for diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Actrapid (insulin human regular)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus. MAH: Novo Nordisk A/S. Decision date: 24/09/2020